Is Crop Life Scienc overvalued or undervalued?
As of September 17, 2025, Crop Life Science is considered an attractive investment due to its undervalued financial ratios, including a PE Ratio of 15.53 and an EV to EBITDA of 8.81, which are significantly lower than peers like UPL and Bayer CropScience, despite recent underperformance against the Sensex.
As of 17 September 2025, the valuation grade for Crop Life Science has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued based on its financial ratios, which include a PE Ratio of 15.53, an EV to EBITDA of 8.81, and a ROCE of 11.07%. When compared to peers, Crop Life Science's PE ratio is significantly lower than that of UPL at 39.58 and Bayer CropScience at 39.32, both of which are categorized as very expensive. Additionally, the company's EV to EBITDA ratio of 8.81 is more favorable compared to P I Industries, which stands at 25.15. This suggests that Crop Life Science offers a more attractive investment opportunity relative to its peers. Despite a recent underperformance against the Sensex in the short term, the year-to-date return of 19.64% indicates a strong recovery potential.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
